Pathological immune mechanisms are key disease drivers which span therapeutic areas, including inflammatory and autoimmune disease. Whether you strive to dampen excessive inflammatory responses directly, or to therapeutically enhance indirect immunosuppressive mechanisms, you can accelerate your program with our range of new tools, platforms and models, and a collaborative, integrated approach that takes you from proof of concept right the way through to the clinic.
Charles River is perfectly positioned to help you understand your drug discovery project. Our team of experienced immunologists are ready to design tailor-made solutions to support you with your research needs.